Abbott Laboratories
ABT
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irā¦ read more
Healthcare
Medical Devices
46 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$82.57
Price-2.08%
-$1.75
1Y
Price
Market Cap
$143.821b
Large
Price/Earnings 3y Avg5y Avg
23.1x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+16.5%
EBITDA Margin+9.7%
Net Profit Margin+8.2%
Free Cash Flow Margin+16.5%
EBITDA Margin+9.7%
Net Profit Margin+8.2%
Free Cash Flow MarginRevenue
$45.134b
+1.8%
1y CAGR+4.0%
3y CAGR+1.0%
5y CAGREarnings
$6.276b
-3.8%
1y CAGR+26.4%
3y CAGR+15.4%
5y CAGREPS
$3.59
-3.5%
1y CAGR+26.3%
3y CAGR+15.6%
5y CAGRBook Value
$52.701b
$110.429b
Assets$57.728b
Liabilities$34.047b
DebtDebt to Assets
30.8%
3.1x
Debt to EBITDAFree Cash Flow
$7.378b
-0.2%
1y CAGR+13.9%
3y CAGR+1.6%
5y CAGRNo items found.
Press Releases
Statements and updates from the company